We are live on ! Find out more
CTSO icon

Cytosorbents Corp
CTSO

50 hedge funds and large institutions have $9.32M invested in Cytosorbents Corp in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

0.62% less ownership

Funds ownership: 26.85% → 26.23% (-0.62%)

2% less funds holding

Funds holding: 51 → 50 (-1)

14% less capital invested

Capital invested by funds: $10.8M → $9.32M (-$1.46M)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

Holders
50
Holders Change
-1
Holders Change %
-1.96%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$70.6K
2
Neuberger Berman Group
Neuberger Berman Group
New York
+$39.2K
3
RWM
Ritholtz Wealth Management
New York
+$18.7K
4
HF
HRT Financial
New York
+$9.63K
5
BlackRock
BlackRock
New York
+$8.49K

Top Sellers

Rank Fund Capital Flow
1
SC
Skylands Capital
Wisconsin
-$100K
2
GCP
GSA Capital Partners
United Kingdom
-$95K
3
Citadel Advisors
Citadel Advisors
Florida
-$94.5K
4
SIG
Sargent Investment Group
Maryland
-$42.4K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$36.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$17K -$36.5K -53,418 -64%
KAS
27
Kestra Advisory Services
Texas
$16K +$1.71K +2,500 +10%
EWA
28
EP Wealth Advisors
California
$15.9K – – –
RWM
29
Ritholtz Wealth Management
New York
$15.5K +$18.7K +27,443 New
LPL Financial
30
LPL Financial
California
$13.1K +$81 +119 +0.5%
Creative Planning
31
Creative Planning
Kansas
$12.1K – – –
SAM
32
Seelaus Asset Management
New Jersey
$9.23K -$683 -1,000 -6%
MFG
33
Merit Financial Group
Georgia
$8.66K – – –
FNBOO
34
First National Bank of Omaha
Nebraska
$8.52K – – –
VGA
35
Vanguard Global Advisers
Pennsylvania
$7.85K +$9.46K +13,865 New
HF
36
HRT Financial
New York
$7K +$9.63K +14,113 New
TCBWMS
37
Texas Capital Bank Wealth Management Services
Texas
$6.23K – – –
Citadel Advisors
38
Citadel Advisors
Florida
$6.12K -$94.5K -138,480 -93%
MCM
39
Marathon Capital Management
Maryland
$5.66K +$6.83K +10,000 New
Fifth Third Bancorp
40
Fifth Third Bancorp
Ohio
$1.75K +$2.1K +3,082 New
Rockefeller Capital Management
41
Rockefeller Capital Management
New York
$1.05K -$481 -705 -27%
JP Morgan Chase
42
JP Morgan Chase
New York
$208 – – –
YAL
43
Your Advocates Ltd
Texas
$143 – – –
Wells Fargo
44
Wells Fargo
California
$142 -$328 -480 -66%
MCM
45
MAI Capital Management
Ohio
$132 – – –
Jones Financial Companies
46
Jones Financial Companies
Missouri
$55 – – –
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$18 – – –
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$10 -$2 -3 -15%
FFA
49
Farther Finance Advisors
California
$3 +$4 +6 New
SS
50
SBI Securities
Japan
$1 +$1 +1 New
1
2
3

CTSO Hedge Fund Activity: Q1 2026 in Review

50 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2026, worth a combined $9.32M — down 14% from $10.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CTSO positions and 7 closed out — a net gain of 3 holders — while 9 added to existing stakes and 12 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $70.6K. The largest seller was Skylands Capital, cutting an estimated $100K.

  • 50 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2026, down from 51 in Q4 2025.
  • Funds reported $9.32M of Cytosorbents Corp stock for Q1 2026, down 14% quarter-over-quarter.
  • 10 funds opened new Cytosorbents Corp positions in Q1 2026 and 7 closed out, a net change of +3 holders.
  • The largest Cytosorbents Corp buyer in Q1 2026 was Geode Capital Management, an estimated $70.6K added.
  • The largest Cytosorbents Corp seller in Q1 2026 was Skylands Capital, an estimated $100K sold.

Based on aggregated 13F filings for Q1 2026.